Fiche société
University of Arkansas
Traitements, essais et publications liés.
Traitements3programmes
Essais2liés
Publications7liées
SourceDBlocale
Traitements
3| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| RFA ApplicatorThe purpose of this study is to build a device that will consistently ablate (destroy or remove) cavitary breast tissue after a formal breast cancer resection in order to mimic the tissue that is now irradiated after breast cancer lumpectomy. The device would be easier to handle, perform the ablation in less time and by so ablating this margin would avoid the need in many for reoperation to obtain negative margins and based on preliminary data avoid the need for radiation. This would be especially important in poor and rural patients and would lead to decreased costs of treatment in patients with favorable breast cancer. | Cancer | Non applicable | À vérifier | United States | À vérifier |
| TurmericThe goal of this clinical trial is to assess the feasibility of adding a combination of metformin and turmeric as part of a nutritional intervention regimen to the current standard of care, namely, intermittent Androgen Deprivation Therapy (iADT), for patients with castration sensitive biochemical progressive prostate cancer. The main objectives are: * Assess the feasibility of the study population and enrollment. * Evaluate time to PSA relapse with nutritional intervention on iADT. Participants who are receiving iADT will be dispensed Metformin and turmeric and complete a pill diary. Participants will also have blood and stool samples collected and complete quality of life questionnaires. The long-term goal is to further assess the efficacy and safety of this nutritional regimen and the roles of metabolic syndrome, microenvironment/microbiome, and genomic vs epigenomic profiles in the care of these patients through a clinical trial. | Cancer | Phase 1 | À vérifier | United States | À vérifier |
| RFA ApplicatorThe purpose of this study is to build a device that will consistently ablate (destroy or remove) cavitary breast tissue after a formal breast cancer resection in order to mimic the tissue that is now irradiated after breast cancer lumpectomy. The device would be easier to handle, perform the ablation in less time and by so ablating this margin would avoid the need in many for reoperation to obtain negative margins and based on preliminary data avoid the need for radiation. This would be especially important in poor and rural patients and would lead to decreased costs of treatment in patients with favorable breast cancer. | Cancer | Non applicable | À vérifier | United States | À vérifier |
Essais cliniques
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| RFA Applicator | Cancer | Non applicable | NCT02525913 | Feasibility Study of Cavity Radiofrequency Ablation in ex Vivo Mastectomy Breast Tissue | WITHDRAWN |
| Metformin | Cancer | Phase 1 | NCT06044025 | A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy | RECRUITING |
Publications
7| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Turmeric | Low, plasma level‑informed native curcumin concentrations fail to induce cell death in human lung and colorectal cancer cells. | Pharmaceutical biology | ||
| Turmeric | Rarely reported cases of hepatotoxicity associated with turmeric- and curcuminoid-containing dietary supplements: a comprehensive review by USP. | Pharmaceutical biology | ||
| Turmeric | Optimal dose window, formulation efficacy, and molecular mechanisms of curcumin in MASLD animal models: A systematic review and three-level meta-analysis. | Journal of ethnopharmacology | ||
| Turmeric | Hydrophobic Deep Eutectic Solvent-Derived Curcuminoids Loaded into a Double-Layer Colloidal Delivery System: Physicochemical Properties and In Vitro Biological Activity. | Foods (Basel, Switzerland) | ||
| Turmeric | Enhanced Oral Delivery of Turmeric Extract via Spray-Dried Microparticles: Biopharmaceutical Performance and In Vitro Microbiota Modulation. | International journal of molecular sciences | ||
| Turmeric | Plant-derived mitochondria mitigate aging-related neurodegeneration by reprogramming microglial mitochondrial energy metabolism. | Translational neurodegeneration | ||
| Turmeric | Turmeric-derived mesoporous carbon as a bioactive material: In vitro anticancer, antidiabetic, and anti-inflammatory evaluation. | Bioorganic chemistry |